368 related articles for article (PubMed ID: 26730528)
1. Response of Aneurysmal Bone Cyst to Denosumab.
Skubitz KM; Peltola JC; Santos ER; Cheng EY
Spine (Phila Pa 1976); 2015 Nov; 40(22):E1201-4. PubMed ID: 26730528
[TBL] [Abstract][Full Text] [Related]
2. Interest of Denosumab for the Treatment of Giant-cells Tumors and Aneurysmal Bone Cysts of the Spine. About Nine Cases.
Dubory A; Missenard G; Domont J; Court C
Spine (Phila Pa 1976); 2016 Jun; 41(11):E654-E660. PubMed ID: 27244112
[TBL] [Abstract][Full Text] [Related]
3. Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results.
Palmerini E; Ruggieri P; Angelini A; Boriani S; Campanacci D; Milano GM; Cesari M; Paioli A; Longhi A; Abate ME; Scoccianti G; Terzi S; Trovarelli G; Franchi A; Picci P; Ferrari S; Leopardi MP; Pierini M
Tumori; 2018 Oct; 104(5):344-351. PubMed ID: 30086700
[TBL] [Abstract][Full Text] [Related]
4. Denosumab: a potential treatment option for aneurysmal bone cyst of the atlas.
Patel RS; Dhamne CA; Gopinathan A; Kumar N; Kumar N
Eur Spine J; 2018 Jul; 27(Suppl 3):494-500. PubMed ID: 29470716
[TBL] [Abstract][Full Text] [Related]
5. Denosumab: non-surgical treatment option for selective arterial embolization resistant aneurysmal bone cyst of the spine and sacrum. Case report.
Ghermandi R; Terzi S; Gasbarrini A; Boriani S
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3692-5. PubMed ID: 27649673
[TBL] [Abstract][Full Text] [Related]
6. Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report.
Del Sindaco G; Berlanga P; Brugières L; Thebault E; Mantovani G; Wicart P; Linglart A
Front Endocrinol (Lausanne); 2021; 12():698963. PubMed ID: 34335473
[TBL] [Abstract][Full Text] [Related]
7. Denosumab: A potential new treatment option for recurrent Aneurysmal Bone Cyst of the spine.
Kulkarni AG; Patel A
SICOT J; 2019; 5():10. PubMed ID: 30931897
[TBL] [Abstract][Full Text] [Related]
8. Targeting receptor-activator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response.
Pelle DW; Ringler JW; Peacock JD; Kampfschulte K; Scholten DJ; Davis MM; Mitchell DS; Steensma MR
Transl Res; 2014 Aug; 164(2):139-48. PubMed ID: 24726460
[TBL] [Abstract][Full Text] [Related]
9. Aneurysmal bone cyst: results of an off label treatment with Denosumab.
Dürr HR; Grahneis F; Baur-Melnyk A; Knösel T; Birkenmaier C; Jansson V; Klein A
BMC Musculoskelet Disord; 2019 Oct; 20(1):456. PubMed ID: 31630689
[TBL] [Abstract][Full Text] [Related]
10. Denosumab for treating aneurysmal bone cysts in children.
Raux S; Bouhamama A; Gaspar N; Brugières L; Entz-Werlé N; Mallet C; Dijoud F; Gouin F; Marec-Bérard P
Orthop Traumatol Surg Res; 2019 Oct; 105(6):1181-1185. PubMed ID: 31358461
[TBL] [Abstract][Full Text] [Related]
11. Denosumab in the management of Aneurysmal bone cyst.
Maximen J; Robin F; Tronchot A; Rossetti A; Ropars M; Guggenbuhl P
Joint Bone Spine; 2022 Jan; 89(1):105260. PubMed ID: 34481945
[TBL] [Abstract][Full Text] [Related]
12. Massive aneurysmal bone cyst of the skull base treated with denosumab.
Asi KW; Abdelmeguid A; Bell D; Hanna EY
Head Neck; 2018 Dec; 40(12):E107-E113. PubMed ID: 30475414
[TBL] [Abstract][Full Text] [Related]
13. Effect of denosumab on recurrent giant cell reparative granuloma of the lumbar spine.
Akeda K; Kasai Y; Sakakibara T; Matsumine A; Takegami N; Yamada J; Sudo A
Spine (Phila Pa 1976); 2015 May; 40(10):E601-8. PubMed ID: 25955096
[TBL] [Abstract][Full Text] [Related]
14. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Sasaki T; Hatano H; Hotta T; Endo N
PLoS One; 2016; 11(5):e0154680. PubMed ID: 27163152
[TBL] [Abstract][Full Text] [Related]
15. The role of neoadjuvant denosumab in the treatment of aneurysmal bone cysts: a case series and review of the literature.
Giantini-Larsen AM; Chakravarthy VB; Barzilai O; Newman WC; Wexler L; Bilsky MH
J Neurosurg Pediatr; 2022 Dec; 30(6):547-554. PubMed ID: 36282899
[TBL] [Abstract][Full Text] [Related]
16. Denosumab Treatment for Giant Cell Tumors, Aneurysmal Bone Cysts, and Fibrous Dysplasia-Risks and Benefits.
Pan KS; Boyce AM
Curr Osteoporos Rep; 2021 Apr; 19(2):141-150. PubMed ID: 33616817
[TBL] [Abstract][Full Text] [Related]
17. Surgical Management and Denosumab for Aneurysmal Bone Cysts of the Spine in an Australian Tertiary Paediatric Centre.
Vanderniet JA; Tsinas D; Wall CL; Girgis CM; London K; Keane C; Briody J; Hibbert S; Poon M; Padhye B; Biggin A; Dalla-Pozza L; Gray RJ; Munns CF
Calcif Tissue Int; 2023 May; 112(5):592-602. PubMed ID: 36810677
[TBL] [Abstract][Full Text] [Related]
18. Denosumab and sclerotherapy for recurrent spinal aneurysmal bone cyst in a child.
Singh R; Madasswery S; Colman M; Kent PM
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38589235
[TBL] [Abstract][Full Text] [Related]
19. Giant cell tumour of bone in the denosumab era.
van der Heijden L; Dijkstra PDS; Blay JY; Gelderblom H
Eur J Cancer; 2017 May; 77():75-83. PubMed ID: 28365529
[TBL] [Abstract][Full Text] [Related]
20. Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts.
Lange T; Stehling C; Fröhlich B; Klingenhöfer M; Kunkel P; Schneppenheim R; Escherich G; Gosheger G; Hardes J; Jürgens H; Schulte TL
Eur Spine J; 2013 Jun; 22(6):1417-22. PubMed ID: 23455951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]